Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 2 hours 6 min ago

Bayer wins FDA approval for Gadavist

16/07/2019
CAD is the most common type of heart disease in the United States, as up to one half of middle aged men and one third of middle aged women in the US are at risk of developing CAD during their lifetime.

PRAC recommends new measures for methotrexate

16/07/2019
Decisions include restricting who can prescribe these medicines, making warnings on the packaging more prominent and providing educational materials.

AZ’ Farxiga hit with complete response letter

15/07/2019
AstraZeneca has said that it will work closely with the FDA to discuss the next steps.

Success for GSK’s Zejula in ovarian cancer

15/07/2019
The drug was found to demonstrate significant improvement in progression free survival for women regardless of their biomarker status.

Gilead, Galapagos form $5.1b R&D partnership

15/07/2019
Galapagos will receive a $3.95 billion upfront payment and a $1.1 billion equity investment from Gilead, which it will use to expand and accelerate its research and development programs.

NICE recommends Skyrizi, Forxiga

15/07/2019
The recommendations are for the indication of plaque psoriasis and type I diabetes, respectively.

Record number of children hospitalised for eating disorders

15/07/2019
An overwhelming 91% of those admitted were of girls, and 1,326 of them were girls aged 13 to 17 years.

Immune cell discovery could help provide endometriosis relief

12/07/2019
Currently, endometriosis treatment options are limited to surgical removal of lesions or medical management to suppress ovarian hormone production.

Another Alzheimer’s setback as Amgen, Novartis abandon BACE inhibitor trial

12/07/2019
Sponsors concluded that the potential benefit for participants in the studies did not outweigh the risk.

Orphan Drug Designation granted for AZ’ Imfinzi

12/07/2019
The decision comes hot on the heels of the Phase III CASPIAN trial, which met its primary endpoint.

Experts identify six ways to speed up dementia research

12/07/2019
The work, funded by Alzheimer’s Research UK, calls for a fresh focus on how research is conducted.

Pairing targeted drugs could overcome breast, lung cancer treatment resistance

12/07/2019
The new data could broaden the clinical use of palbociclib – and other drugs that work in the same way – beyond breast cancer to include many other tumour types as well.

BMJ data suggests link between sugary drinks and cancer

11/07/2019
100 ml increase in sugary drinks each day was associated with an 18% increased risk of overall cancer and a 22% increased risk of breast cancer.

FDA set to review Sanofi’s isatuximab for multiple myeloma

11/07/2019
Multiple myeloma is the second most common hematologic malignancy, affecting more than 138,0002 people worldwide.

Nursing degree applications at 'crisis point'

11/07/2019
Applications in England have fallen 29% since the bursary was removed in 2016.

NIHR to invest £135m to tackle system challenges

11/07/2019
The five-year plan will join up some of the country’s best universities, leading innovators and local authorities to solve some of the biggest issues facing health and social care.

NICE recommends gammaCore for cluster headaches

11/07/2019
The portable technology aims to modify pain signals by stimulating the vagus nerve through the skin of the neck.

HPV vaccine to be offered to school-age boys

11/07/2019
Girls have been offered the jab free from the NHS since 2008.

NHS improvements can't happen ‘overnight’, says NHS Confederation

10/07/2019
The King’s Fund Quarterly Monitoring Report suggested that patients face a long wait before they will see improvements in care as a result of the government’s £20 billion NHS funding boost.

GSK’s Dovato hits endpoints in late-stage study

10/07/2019
In a Phase III study the drug combo was as effective in controlling HIV-1 as a Vemlidy combo.

Pages

X